2004
DOI: 10.1016/j.bbamcr.2003.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor κB ligand and MAPK

Abstract: Osteoprotegerin (OPG) is a decoy receptor for receptor activator of nuclear factor kappaB ligand (RANKL), an inducer of osteoclastogenesis via its receptor RANK. We recently demonstrated that OPG also exerts a direct effect in osteoclasts by regulating protease expression. Herein, we showed that OPG-induced pro-matrix metalloproteinase-9 activity was abolished by ras/MAPK inhibitors in purified osteoclasts. OPG induced the phosphorylation of p38 and ERK1/2 in RAW264.7 cells. Only p38 activation was totally abo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
29
0

Year Published

2005
2005
2011
2011

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(31 citation statements)
references
References 22 publications
2
29
0
Order By: Relevance
“…On the other hand, when recombinant RANK-CRD-OPG-DCRD protein was added to the medium, little clustering of RANKL at the plasma membrane was observed (data not shown), indicating that the property as a cross-linker for RANKL is much weaker in this chimeric protein. A previous report showing that the binding sites of RANKL to RANK and RANKL to OPG are somewhat different from each other (37) also supports the preceding observation. In addition, we also investigated the interaction between OPG and Vps33a because we have previously shown the involvement of Vps33a in the transfer of newly synthesized RANKL to the lysosomes in osteoblastic cells.…”
Section: Discussionsupporting
confidence: 84%
“…On the other hand, when recombinant RANK-CRD-OPG-DCRD protein was added to the medium, little clustering of RANKL at the plasma membrane was observed (data not shown), indicating that the property as a cross-linker for RANKL is much weaker in this chimeric protein. A previous report showing that the binding sites of RANKL to RANK and RANKL to OPG are somewhat different from each other (37) also supports the preceding observation. In addition, we also investigated the interaction between OPG and Vps33a because we have previously shown the involvement of Vps33a in the transfer of newly synthesized RANKL to the lysosomes in osteoblastic cells.…”
Section: Discussionsupporting
confidence: 84%
“…(25) Histochemical staining for tartaric acidresistant alkaline phosphatase (ALP) showed that, after a…”
Section: Culturing Of Primary Osteoblastic Cells Bone Marrow Osteoprmentioning
confidence: 99%
“…45,46 Osteoprotegerin promotes MMP activity both directly and indirectly (i.e., by stabilizing RANKL activity). 45,47,48 The role of OPG in calcium homeostasis could also be pathophysiologically relevant. Calcium signals regulate OPG expression, 49,50 and a calcium antagonist traditionally used to prevent cardiovascular disease was recently found to have neuroprotective effects.…”
Section: Discussionmentioning
confidence: 99%